A QUEBEC COMPANY
FOUNDED BY A PHARMACIST

Home > News

What's new in RxVigilance

The 2017 Hypertension Canada Guidelines for the Management of Hypertension and the What?s New in 2017? overview are now available in the Professional Documentation section.

Following the recent publication of the last part of the Canadian Contraception Consensus by the SOGC, a comprehensive review of the hormonal contraception table has been completed.  Information has been updated and new sections have been added, including Quick Start methods for various contraceptives and switching from one contraceptive to another.

A comprehensive review of the document on drug-induced serotonin toxicity (also known as serotonin syndrome) has been completed.A new patient handout on the causes, symptoms and prevention of serotonin toxicity has also been added.

There is a new sheet available in RxVigilance for pharmacists participating in the Fentanyl Patch-for-Patch Return Program on which patients can affix their used patches.

The Patch4patch program, already implemented in certain provinces, is an opportunity to work with your patients to ensure the safe disposal of fentanyl patches and reduce misuse on the black market.

Starting this May, the home screen will have a more streamlined, user-friendly and dynamic look. Users will be able to enjoy new features, while still having quick and easy access to RxVigilance content. You will notice, upon using the Search box, that the results are presented in a way that is clearer and easier to consult. We will also be revamping the product monographs! We cannot wait for you to see all the changes to RxVigilance. 

DISCOVER

OUR PRODUCTS

A software package that provides information on drugs, health products and disease.
Learn more
Our reference tool for health care professionals that features information on drugs and health, now accessible from anywhere.
Learn more

OUR TOOLS WHICH HAVE NOW BECOME INDISPENSABLE

AIM TO ENSURE THE SAFE AND OPTIMAL USE OF DRUGS

Our partners